HEADER TRANSFERASE 15-SEP-09 2WTC TITLE CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 210-531; COMPND 5 SYNONYM: CHECKPOINT KINASE 2, CDS1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PTHREE-E KEYWDS TRANSFERASE, KINASE, CELL CYCLE, LI-FRAUMENI SYNDROME EXPDTA X-RAY DIFFRACTION AUTHOR S.HILTON,S.NAUD,J.J.CALDWELL,K.BOXALL,S.BURNS,V.E.ANDERSON,L.ANTONI, AUTHOR 2 C.E.ALLEN,L.H.PEARL,A.W.OLIVER,G.W.AHERNE,M.D.GARRETT,I.COLLINS REVDAT 4 20-DEC-23 2WTC 1 REMARK REVDAT 3 16-FEB-10 2WTC 1 JRNL REMARK REVDAT 2 12-JAN-10 2WTC 1 JRNL REVDAT 1 29-DEC-09 2WTC 0 JRNL AUTH S.HILTON,S.NAUD,J.J.CALDWELL,K.BOXALL,S.BURNS,V.E.ANDERSON, JRNL AUTH 2 L.ANTONI,C.E.ALLEN,L.H.PEARL,A.W.OLIVER,G.W.AHERNE, JRNL AUTH 3 M.D.GARRETT,I.COLLINS JRNL TITL IDENTIFICATION AND CHARACTERISATION OF 2-AMINOPYRIDINE JRNL TITL 2 INHIBITORS OF CHECKPOINT KINASE 2 JRNL REF BIOORG.MED.CHEM. V. 18 707 2010 JRNL REFN ISSN 0968-0896 JRNL PMID 20022510 JRNL DOI 10.1016/J.BMC.2009.11.058 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 9124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.4114 - 4.3245 0.99 2939 167 0.1672 0.2202 REMARK 3 2 4.3245 - 3.4337 1.00 2861 158 0.1659 0.2374 REMARK 3 3 3.4337 - 3.0000 1.00 2844 155 0.2437 0.2874 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 57.27 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 1.000 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 78.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.16150 REMARK 3 B22 (A**2) : -8.16150 REMARK 3 B33 (A**2) : 16.32300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2352 REMARK 3 ANGLE : 1.141 3174 REMARK 3 CHIRALITY : 0.066 363 REMARK 3 PLANARITY : 0.004 393 REMARK 3 DIHEDRAL : 17.951 896 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WTC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1290041147. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9145 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.070 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.68000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.150 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2CN5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM REMARK 280 NITRATE, 8-16% (W/V) PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.69333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.84667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.84667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 61.69333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 203 REMARK 465 PRO A 204 REMARK 465 LEU A 205 REMARK 465 GLY A 206 REMARK 465 SER A 207 REMARK 465 HIS A 208 REMARK 465 MET A 209 REMARK 465 SER A 210 REMARK 465 GLY A 229 REMARK 465 ALA A 230 REMARK 465 CYS A 231 REMARK 465 GLY A 232 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 GLY A 376 REMARK 465 GLU A 377 REMARK 465 ALA A 513 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 465 GLU A 531 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 268 CG CD1 CD2 REMARK 470 GLU A 271 CB CG CD OE1 OE2 REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 GLU A 295 OE1 OE2 REMARK 470 LYS A 373 CE NZ REMARK 470 MET A 381 CG SD CE REMARK 470 ARG A 382 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 444 CD CE NZ REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 470 ARG A 493 CD NE CZ NH1 NH2 REMARK 470 LYS A 494 CE NZ REMARK 470 LEU A 512 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 213 152.14 -44.94 REMARK 500 SER A 223 -142.43 -112.70 REMARK 500 ASN A 281 88.28 -152.10 REMARK 500 ALA A 294 -139.67 -136.87 REMARK 500 ASN A 316 28.17 21.69 REMARK 500 ARG A 346 -2.65 71.75 REMARK 500 ASP A 347 47.83 -142.35 REMARK 500 ASP A 368 76.17 62.27 REMARK 500 THR A 383 -38.76 -36.01 REMARK 500 ALA A 407 -16.09 -47.51 REMARK 500 ARG A 431 62.32 62.17 REMARK 500 THR A 432 139.84 -173.00 REMARK 500 SER A 435 171.96 -52.86 REMARK 500 ASN A 446 99.66 -47.83 REMARK 500 LEU A 467 43.58 -88.24 REMARK 500 ARG A 474 150.18 -49.20 REMARK 500 GLN A 496 -71.53 -45.55 REMARK 500 LEU A 499 -72.24 -59.44 REMARK 500 ALA A 507 101.39 -51.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VGM A 1513 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 1514 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR DBREF 2WTC A 203 209 PDB 2WTC 2WTC 203 209 DBREF 2WTC A 210 531 UNP O96017 CHK2_HUMAN 210 531 SEQRES 1 A 329 GLY PRO LEU GLY SER HIS MET SER VAL TYR PRO LYS ALA SEQRES 2 A 329 LEU ARG ASP GLU TYR ILE MET SER LYS THR LEU GLY SER SEQRES 3 A 329 GLY ALA CYS GLY GLU VAL LYS LEU ALA PHE GLU ARG LYS SEQRES 4 A 329 THR CYS LYS LYS VAL ALA ILE LYS ILE ILE SER LYS ARG SEQRES 5 A 329 LYS PHE ALA ILE GLY SER ALA ARG GLU ALA ASP PRO ALA SEQRES 6 A 329 LEU ASN VAL GLU THR GLU ILE GLU ILE LEU LYS LYS LEU SEQRES 7 A 329 ASN HIS PRO CYS ILE ILE LYS ILE LYS ASN PHE PHE ASP SEQRES 8 A 329 ALA GLU ASP TYR TYR ILE VAL LEU GLU LEU MET GLU GLY SEQRES 9 A 329 GLY GLU LEU PHE ASP LYS VAL VAL GLY ASN LYS ARG LEU SEQRES 10 A 329 LYS GLU ALA THR CYS LYS LEU TYR PHE TYR GLN MET LEU SEQRES 11 A 329 LEU ALA VAL GLN TYR LEU HIS GLU ASN GLY ILE ILE HIS SEQRES 12 A 329 ARG ASP LEU LYS PRO GLU ASN VAL LEU LEU SER SER GLN SEQRES 13 A 329 GLU GLU ASP CYS LEU ILE LYS ILE THR ASP PHE GLY HIS SEQRES 14 A 329 SER LYS ILE LEU GLY GLU THR SER LEU MET ARG THR LEU SEQRES 15 A 329 CYS GLY THR PRO THR TYR LEU ALA PRO GLU VAL LEU VAL SEQRES 16 A 329 SER VAL GLY THR ALA GLY TYR ASN ARG ALA VAL ASP CYS SEQRES 17 A 329 TRP SER LEU GLY VAL ILE LEU PHE ILE CYS LEU SER GLY SEQRES 18 A 329 TYR PRO PRO PHE SER GLU HIS ARG THR GLN VAL SER LEU SEQRES 19 A 329 LYS ASP GLN ILE THR SER GLY LYS TYR ASN PHE ILE PRO SEQRES 20 A 329 GLU VAL TRP ALA GLU VAL SER GLU LYS ALA LEU ASP LEU SEQRES 21 A 329 VAL LYS LYS LEU LEU VAL VAL ASP PRO LYS ALA ARG PHE SEQRES 22 A 329 THR THR GLU GLU ALA LEU ARG HIS PRO TRP LEU GLN ASP SEQRES 23 A 329 GLU ASP MET LYS ARG LYS PHE GLN ASP LEU LEU SER GLU SEQRES 24 A 329 GLU ASN GLU SER THR ALA LEU PRO GLN VAL LEU ALA GLN SEQRES 25 A 329 PRO SER THR SER ARG LYS ARG PRO ARG GLU GLY GLU ALA SEQRES 26 A 329 GLU GLY ALA GLU HET VGM A1513 25 HET NO3 A1514 4 HETNAM VGM 4-[2-AMINO-5-(4-HYDROXY-3-METHOXYPHENYL)PYRIDIN-3- HETNAM 2 VGM YL]BENZAMIDE HETNAM NO3 NITRATE ION FORMUL 2 VGM C19 H17 N3 O3 FORMUL 3 NO3 N O3 1- FORMUL 4 HOH *31(H2 O) HELIX 1 1 PRO A 213 ASP A 218 1 6 HELIX 2 2 PRO A 266 LEU A 280 1 15 HELIX 3 3 LEU A 309 VAL A 313 5 5 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 THR A 378 CYS A 385 1 8 HELIX 6 6 THR A 387 LEU A 391 5 5 HELIX 7 7 ALA A 392 VAL A 399 1 8 HELIX 8 8 ARG A 406 LEU A 413 1 8 HELIX 9 9 VAL A 415 SER A 422 1 8 HELIX 10 10 SER A 435 SER A 442 1 8 HELIX 11 11 ILE A 448 ALA A 453 1 6 HELIX 12 12 SER A 456 LEU A 467 1 12 HELIX 13 13 THR A 476 ARG A 482 1 7 HELIX 14 14 HIS A 483 GLN A 487 5 5 HELIX 15 15 ASP A 488 GLU A 504 1 17 SHEET 1 AA 5 TYR A 220 THR A 225 0 SHEET 2 AA 5 VAL A 234 GLU A 239 -1 O LEU A 236 N SER A 223 SHEET 3 AA 5 LYS A 245 SER A 252 -1 O VAL A 246 N ALA A 237 SHEET 4 AA 5 ASP A 296 LEU A 301 -1 O TYR A 297 N ILE A 251 SHEET 5 AA 5 ILE A 288 ASP A 293 -1 N LYS A 289 O VAL A 300 SHEET 1 AB 2 VAL A 353 LEU A 355 0 SHEET 2 AB 2 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SITE 1 AC1 10 LEU A 226 LYS A 249 LEU A 301 GLU A 302 SITE 2 AC1 10 LEU A 303 MET A 304 GLU A 305 LEU A 354 SITE 3 AC1 10 THR A 367 ASP A 368 SITE 1 AC2 5 LEU A 375 GLY A 403 TYR A 404 ASN A 405 SITE 2 AC2 5 ARG A 406 CRYST1 90.820 90.820 92.540 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011011 0.006357 0.000000 0.00000 SCALE2 0.000000 0.012714 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010806 0.00000